| Year |
Citation |
Score |
| 2024 |
Tahsin S, Sane NS, Cernyar B, Jiang L, Zohar Y, Lee BR, Miranti CK. AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production. Oncogene. PMID 38769192 DOI: 10.1038/s41388-024-03064-7 |
0.586 |
|
| 2024 |
Jiang L, Khawaja H, Tahsin S, Clarkson TA, Miranti CK, Zohar Y. Microfluidic-based human prostate-cancer-on-chip. Frontiers in Bioengineering and Biotechnology. 12: 1302223. PMID 38322789 DOI: 10.3389/fbioe.2024.1302223 |
0.527 |
|
| 2023 |
Hahn AW, Siddiqui BA, Leo J, Dondossola E, Basham KJ, Miranti CK, Frigo DE. Cancer Cell-Extrinsic Roles for the Androgen Receptor in Prostate Cancer. Endocrinology. PMID 37192413 DOI: 10.1210/endocr/bqad078 |
0.559 |
|
| 2023 |
Jensen CC, Clements AN, Liou H, Ball LE, Bethard JR, Langlais PR, Toth RK, Chauhan SS, Casillas AL, Daulat SR, Kraft AS, Cress AE, Miranti CK, Mouneimne G, Rogers GC, et al. PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion. The Journal of Cell Biology. 222. PMID 37042842 DOI: 10.1083/jcb.202208136 |
0.435 |
|
| 2020 |
Dodla P, Bhoopalan V, Khoo SK, Miranti C, Sridhar S. Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82. Bmc Cancer. 20: 1211. PMID 33298014 DOI: 10.1186/s12885-020-07675-7 |
0.375 |
|
| 2020 |
Miranti CK, Moore S, Kim Y, Chappeta VR, Wu K, De B, Gokhale V, Hurley LH, Reyes-Reyes EM. Erratum: Nucleolin represses transcription of the androgen receptor gene through a G-quadruplex. Oncotarget. 11: 2586. PMID 32655842 DOI: 10.18632/Oncotarget.27661 |
0.306 |
|
| 2020 |
Nollet EA, Cardo-Vila M, Ganguly SS, Tran JD, Schulz VV, Cress A, Corey E, Miranti CK. Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer. Oncogene. PMID 32565538 DOI: 10.1038/S41388-020-1370-9 |
0.602 |
|
| 2020 |
Miranti CK, Moore S, Kim Y, Chappeta VR, Wu K, De B, Gokhale V, Hurley LH, Reyes-Reyes EM. Nucleolin represses transcription of the androgen receptor gene through a G-quadruplex. Oncotarget. 11: 1758-1776. PMID 32477465 DOI: 10.18632/Oncotarget.27589 |
0.592 |
|
| 2019 |
Jiang L, Ivich F, Tahsin S, Tran M, Frank SB, Miranti CK, Zohar Y. Human stroma and epithelium co-culture in a microfluidic model of a human prostate gland. Biomicrofluidics. 13: 064116. PMID 31768202 DOI: 10.1063/1.5126714 |
0.543 |
|
| 2019 |
Toth RK, Tran JD, Muldong MT, Nollet EA, Schulz VV, Jensen CC, Hazlehurst LA, Corey E, Durden D, Jamieson C, Miranti CK, Warfel NA. Hypoxia-induced PIM kinase and laminin-activated integrin α6 mediate resistance to PI3K inhibitors in bone-metastatic CRPC. American Journal of Clinical and Experimental Urology. 7: 297-312. PMID 31511835 |
0.367 |
|
| 2019 |
Ganguly SS, Hostetter G, Tang L, Frank SB, Saboda K, Mehra R, Wang L, Li X, Keller ET, Miranti CK. Notch3 promotes prostate cancer-induced bone lesion development via MMP-3. Oncogene. PMID 31467432 DOI: 10.1038/S41388-019-0977-1 |
0.47 |
|
| 2019 |
Rubenstein CS, Gard JMC, Wang M, McGrath JE, Ingabire N, Hinton JP, Marr KD, Simpson SJ, Nagle RB, Miranti CK, Warfel NA, Garcia JGN, Arif-Tiwari H, Cress AE. Gene editing of α6 integrin inhibits muscle invasive networks and increases cell-cell biophysical properties in prostate cancer. Cancer Research. PMID 31337652 DOI: 10.1158/0008-5472.Can-19-0868 |
0.479 |
|
| 2019 |
Bergsma A, Ganguly SS, Wiegand ME, Dick D, Williams BO, Miranti CK. Regulation of cytoskeleton and adhesion signaling in osteoclasts by tetraspanin CD82. Bone Reports. 10: 100196. PMID 30788390 DOI: 10.1016/J.Bonr.2019.100196 |
0.305 |
|
| 2018 |
Das L, Gard JMC, Prekeris R, Nagle RB, Morrissey C, Knudsen BS, Miranti CK, Cress AE. Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer. Molecular Cancer Research : McR. PMID 29759989 DOI: 10.1158/1541-7786.Mcr-17-0589 |
0.551 |
|
| 2018 |
Nollet E, Ganguly S, Schulz V, Corey E, Miranti CK. Abstract A083: Cell adhesion to laminin, by integrin α6β1, mediates drug resistance to PI3K in castration-resistant prostate cancer through AR-dependent induction of BNIP3 Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-A083 |
0.647 |
|
| 2017 |
Frank SB, Berger PL, Ljungman M, Miranti CK. Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC. Journal of Cell Science. PMID 28446540 DOI: 10.1242/jcs.197152 |
0.581 |
|
| 2016 |
Berger PL, Winn ME, Miranti CK. Miz1, a Novel Target of ING4, Can Drive Prostate Luminal Epithelial Cell Differentiation. The Prostate. PMID 27527891 DOI: 10.1002/Pros.23249 |
0.578 |
|
| 2016 |
Tesfay L, Schulz VV, Frank SB, Lamb LE, Miranti CK. Receptor Tyrosine Kinase Met Promotes Cell Survival via Kinase-Independent Maintenance of Integrin α3β1. Molecular Biology of the Cell. PMID 27307589 DOI: 10.1091/Mbc.E15-09-0649 |
0.643 |
|
| 2016 |
Zarif JC, Miranti CK. The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance. Cellular Signalling. 28: 348-56. PMID 26829214 DOI: 10.1016/J.Cellsig.2016.01.013 |
0.771 |
|
| 2016 |
Meng X, Vander Ark A, Lee P, Hostetter G, Bhowmick NA, Matrisian LM, Williams BO, Miranti CK, Li X. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis. Oncogene. 35: 2370-8. PMID 26279296 DOI: 10.1038/Onc.2015.297 |
0.35 |
|
| 2016 |
Krishnan V, Mitchell K, Miska J, George S, Shaw P, Seewaldt V, Lesniak M, Chekmareva M, Becker L, Parkash V, Miranti C, Rinker-Schaeffer C. Abstract A82: Ovarian cancer cells hijack immune functions of omental milky spots for metastatic colonization. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A82 |
0.447 |
|
| 2016 |
Berger P, Watson M, Winn M, Miranti CK. Abstract B20: Key intermediate progenitor in luminal prostate epithelial differentiation dictates susceptibility to Myc overexpression and Pten loss in prostate cancer cell of origin Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Devbiolca15-B20 |
0.6 |
|
| 2015 |
Tesfay L, Clausen KA, Kim JW, Hegde P, Wang X, Miller LD, Deng Z, Blanchette N, Arvedson T, Miranti CK, Babitt JL, Lin HY, Peehl DM, Torti FM, Torti SV. Hepcidin regulation in prostate and its disruption in prostate cancer. Cancer Research. 75: 2254-63. PMID 25858146 DOI: 10.1158/0008-5472.Can-14-2465 |
0.57 |
|
| 2015 |
Zarif JC, Lamb LE, Schulz VV, Nollet EA, Miranti CK. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase. Oncotarget. 6: 6862-76. PMID 25730905 DOI: 10.18632/Oncotarget.3119 |
0.787 |
|
| 2015 |
Frank SB, Berger PL, Miranti CK. Abstract B18: Myc governs a prostate epithelial differentiation program involving chromatin remodeling protein ING4 and Notch3: Disruption of which is necessary for human prostate cancer development Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-B18 |
0.624 |
|
| 2014 |
Ganguly SS, Li X, Miranti CK. The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis. Frontiers in Oncology. 4: 364. PMID 25566502 DOI: 10.3389/Fonc.2014.00364 |
0.418 |
|
| 2014 |
Berger PL, Frank SB, Schulz VV, Nollet EA, Edick MJ, Holly B, Chang TT, Hostetter G, Kim S, Miranti CK. Transient induction of ING4 by Myc drives prostate epithelial cell differentiation and its disruption drives prostate tumorigenesis. Cancer Research. 74: 3357-68. PMID 24762396 DOI: 10.1158/0008-5472.Can-13-3076 |
0.61 |
|
| 2013 |
Frank SB, Miranti CK. Disruption of prostate epithelial differentiation pathways and prostate cancer development. Frontiers in Oncology. 3: 273. PMID 24199173 DOI: 10.3389/Fonc.2013.00273 |
0.592 |
|
| 2013 |
Akfirat C, Zhang X, Ventura A, Berel D, Colangelo ME, Miranti CK, Krajewska M, Reed JC, Higano CS, True LD, Vessella RL, Morrissey C, Knudsen BS. Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases. The Journal of Pathology. 230: 291-7. PMID 23420560 DOI: 10.1002/Path.4180 |
0.482 |
|
| 2013 |
Zarif JC, Lamb LE, Miranti CK. Abstract 3801: Androgen Receptor non-genomic regulation of prostate tumor cell invasion and metastasis through Src signaling and Matriptase . Cancer Research. 73: 3801-3801. DOI: 10.1158/1538-7445.Am2013-3801 |
0.803 |
|
| 2012 |
Berger P, Kim S, Miranti CK. Abstract C63: Understanding prostate cancer initiation and development through differentiation: Role of ING4 and Myc in prostate differentiation and cancer development Cancer Research. 72. DOI: 10.1158/1538-7445.Prca2012-C63 |
0.619 |
|
| 2012 |
Zarif JC, Lamb LE, Miranti CK. Abstract A5: Androgen Receptor non-genomic regulation of invasion and metastasis of prostate tumor cells Cancer Research. 72: A5-A5. DOI: 10.1158/1538-7445.Prca2012-A5 |
0.804 |
|
| 2011 |
Lamb LE, Zarif JC, Miranti CK. The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling. Cancer Research. 71: 2739-49. PMID 21310825 DOI: 10.1158/0008-5472.Can-10-2745 |
0.8 |
|
| 2010 |
Lamb LE, Knudsen BS, Miranti CK. E-cadherin-mediated survival of androgen-receptor-expressing secretory prostate epithelial cells derived from a stratified in vitro differentiation model. Journal of Cell Science. 123: 266-76. PMID 20048343 DOI: 10.1242/Jcs.054502 |
0.735 |
|
| 2009 |
Putnam AJ, Schulz VV, Freiter EM, Bill HM, Miranti CK. Src, PKCalpha, and PKCdelta are required for alphavbeta3 integrin-mediated metastatic melanoma invasion. Cell Communication and Signaling : Ccs. 7: 10. PMID 19400942 DOI: 10.1186/1478-811X-7-10 |
0.462 |
|
| 2009 |
Miranti CK. Controlling cell surface dynamics and signaling: How CD82/KAI1 suppresses metastasis Cellular Signalling. 21: 196-211. PMID 18822372 DOI: 10.1016/J.Cellsig.2008.08.023 |
0.348 |
|
| 2007 |
Tolbert WD, Daugherty J, Gao C, Xie Q, Miranti C, Gherardi E, Vande Woude G, Xu HE. A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist. Proceedings of the National Academy of Sciences of the United States of America. 104: 14592-7. PMID 17804794 DOI: 10.1073/Pnas.0704290104 |
0.34 |
|
| 2007 |
Wang X, Zhu J, Zhao P, Jiao Y, Xu N, Grabinski T, Liu C, Miranti CK, Fu T, Cao BB. In vitro efficacy of immuno-chemotherapy with anti-EGFR human Fab-Taxol conjugate on A431 epidermoid carcinoma cells. Cancer Biology & Therapy. 6: 980-7. PMID 17534145 DOI: 10.4161/Cbt.6.6.4197 |
0.333 |
|
| 2007 |
Edick MJ, Tesfay L, Lamb LE, Knudsen BS, Miranti CK. Inhibition of integrin-mediated crosstalk with epidermal growth factor receptor/Erk or Src signaling pathways in autophagic prostate epithelial cells induces caspase-independent death. Molecular Biology of the Cell. 18: 2481-90. PMID 17475774 DOI: 10.1091/Mbc.E06-04-0261 |
0.714 |
|
| 2006 |
Knudsen BS, Miranti CK. The impact of cell adhesion changes on proliferation and survival during prostate cancer development and progression. Journal of Cellular Biochemistry. 99: 345-61. PMID 16676354 DOI: 10.1002/Jcb.20934 |
0.674 |
|
| 2006 |
Sridhar SC, Miranti CK. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases Oncogene. 25: 2367-2378. PMID 16331263 DOI: 10.1038/Sj.Onc.1209269 |
0.478 |
|
| 2004 |
Bill HM, Knudsen B, Moores SL, Muthuswamy SK, Rao VR, Brugge JS, Miranti CK. Epidermal growth factor receptor-dependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells. Molecular and Cellular Biology. 24: 8586-99. PMID 15367678 DOI: 10.1128/Mcb.24.19.8586-8599.2004 |
0.463 |
|
| 2004 |
Lee CC, Putnam AJ, Miranti CK, Gustafson M, Wang LM, Vande Woude GF, Gao CF. Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis. Oncogene. 23: 5193-202. PMID 15122328 DOI: 10.1038/Sj.Onc.1207646 |
0.473 |
|
| 2002 |
Miranti CK. Application of cell adhesion to study signaling networks. Methods in Cell Biology. 69: 359-83. PMID 12071005 DOI: 10.1016/S0091-679X(02)69023-5 |
0.374 |
|
| 2002 |
Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nature Cell Biology. 4: E83-90. PMID 11944041 DOI: 10.1038/Ncb0402-E83 |
0.437 |
|
| 1999 |
Miranti CK, Ohno S, Brugge JS. Protein kinase C regulates integrin-induced activation of the extracellular regulated kinase pathway upstream of Shc Journal of Biological Chemistry. 274: 10571-10581. PMID 10187852 DOI: 10.1074/Jbc.274.15.10571 |
0.408 |
|
| 1998 |
Miranti CK, Leng L, Maschberger P, Brugge JS, Shattil SJ. Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1 Current Biology. 8: 1289-1299. PMID 9843681 DOI: 10.1016/S0960-9822(07)00559-3 |
0.408 |
|
| 1996 |
Xia Z, Dudek H, Miranti CK, Greenberg ME. Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 5425-36. PMID 8757255 DOI: 10.1523/Jneurosci.16-17-05425.1996 |
0.31 |
|
| 1995 |
Miranti CK, Ginty DD, Huang G, Chatila T, Greenberg ME. Calcium activates serum response factor-dependent transcription by a Ras- and Elk-1-independent mechanism that involves a Ca2+/calmodulin-dependent kinase. Molecular and Cellular Biology. 15: 3672-84. PMID 7791774 DOI: 10.1128/Mcb.15.7.3672 |
0.303 |
|
| 1993 |
Rivera VM, Miranti CK, Misra RP, Ginty DD, Chen RH, Blenis J, Greenberg ME. A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. Molecular and Cellular Biology. 13: 6260-73. PMID 8413226 DOI: 10.1128/Mcb.13.10.6260 |
0.326 |
|
| 1990 |
Miranti C, Puck TT. Gene regulation in reverse transformation: cyclic AMP-induced actin homolog in CHO cells. Somatic Cell and Molecular Genetics. 16: 67-78. PMID 2155478 DOI: 10.1007/Bf01650481 |
0.428 |
|
| Show low-probability matches. |